False
Tobias Rosenkranz discusses his work on high concentration protein therapeutics and their viscosity, and what the solutions he has come up with could mean for patients and their medicines.
Conversations about drug formulation with experts from Merck, hosted by The Medicine Maker.
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
January 16, 2023
Almut von der Brelie and Thomas Kipping join us to discuss Merck Parteck® COAT and what it can do for medical formulators and their workflows.
January 16, 2023
Tobias Rosenkranz discusses his work on high concentration protein therapeutics and their viscosity, and what the solutions he has come up with could mean for patients and their medicines.
Discussing the use of different expression formats, from transient through to stable clones, when using Chinese Hamster Ovary cells for biotherapeutic protein production, experts from Lonza and Denmark Technical University share the key considerations of selecting an expression format during biotherapeutic development, and how Lonza’s GS Discovery® solution addresses these.
mRNA therapeutics manufacturing has been a major industrial talking point since its development during the COVID-19 pandemic. Now that CDMOs are developing the technologies and the capacities to scale it up, we find out just how much potential there is in this sector.
Conversations about drug formulation with experts from Merck, hosted by The Medicine Maker.
The Medicine Maker presents a 6 episode series on the inspiring efforts of the Drugs for Neglected Diseases initiative. Tune in and learn just what it takes to develop medicines for some of the world’s most neglected patient populations.
False